Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

Context-dependent role of group 3 innate lymphoid cells in mucosal protection

The Role of ILC3 in Intestinal Immunity

The role of group 3 innate lymphoid cell in intestinal disease

Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells

Group 3 innate lymphoid cells in intestinal health and disease

Group 3 innate lymphoid cells: A trained Gutkeeper

Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis

Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!

Inflammation triggers ILC3 patrolling of the intestinal barrier

Innate lymphoid cells protect host against intestinal pathogen through Id2 dependent IL-22 production and regulation of microbiota. (MUC4P.855)

The Crosstalk Between ILC3s and Adaptive Immunity in Diseases

Innate lymphoid cells — how did we miss them?

The Interaction Network Between Group 3 Innate Lymphoid Cells and Other Cells

A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts

Purification and Adoptive Transfer of Group 3 Gut Innate Lymphoid Cells.

Unveiling the mystery of ILC3s: Their functions and interactions in mucosal immunity.

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

Complementarity and redundancy of IL-22-producing innate lymphoid cells

ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut

The absence of interleukin 10 affects the morphology, differentiation, granule content and the production of cryptidin-4 in Paneth cells in mice

Diet-mediated constitutive induction of novel IL-4+ ILC2 cells maintains intestinal homeostasis in mice